Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions

Introduction: Regulatory agencies encourage the incorporation of the patient voices throughout clinical drug development. Patient-Reported Outcomes (PROs) offer one way of doing this and their use has markedly increased in many therapeutic areas, particularly oncology, in recent years. However, few...

Descripción completa

Detalles Bibliográficos
Autores principales: Cella, David, Chen, Chieh-I, Quek, Ruben G. W., Uribarren, Ainhoa, Reaney, Matthew, Mastey, Vera, Collyar, Deborah, Chassany, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634749/
https://www.ncbi.nlm.nih.gov/pubmed/36339622
http://dx.doi.org/10.3389/fphar.2022.1031992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634749/
https://www.ncbi.nlm.nih.gov/pubmed/36339622
http://dx.doi.org/10.3389/fphar.2022.1031992

Ejemplares similares